← Back to Search

Behavioural Intervention

low-effort session for Prediabetes

N/A
Waitlist Available
Led By Flavio De Castro Magalhaes, PhD
Research Sponsored by University of New Mexico
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Presence of prediabetes (fasting glycemia between 100 and 125 mg/dL or glycated hemoglobin [A1c] between 5.7 and 6.4%) or T2DM (fasting glycemia 126 mg/dL or above or A1c 6.5% or above)
Age between 18 and 65 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up before and 5 minutes after the resistance exercise sessions.
Awards & highlights

Study Summary

This trial is comparing the effect of different levels of effort during a resistance exercise session on blood glucose levels in people with prediabetes or type 2 diabetes. The trial aims to answer whether high effort

Who is the study for?
This trial is for individuals with prediabetes or type 2 diabetes who are interested in how different levels of effort during resistance exercise affect their blood glucose. Participants should be familiar with the exercises and able to commit to multiple sessions.Check my eligibility
What is being tested?
The study tests whether a high-effort or low-effort resistance exercise session can improve blood glucose levels compared to no exercise at all. It also examines participants' enjoyment and discomfort after exercising at different intensities.See study design
What are the potential side effects?
Since this trial involves physical exercise, potential side effects may include muscle soreness, fatigue, and general discomfort associated with exertion. The intensity of these side effects could vary based on the level of effort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have prediabetes or type 2 diabetes based on my blood sugar or A1c levels.
Select...
I am between 18 and 65 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~for 6 hours during the nocturnal period (12 am - 6 am) of each situation (arm) of the study
This trial's timeline: 3 weeks for screening, Varies for treatment, and for 6 hours during the nocturnal period (12 am - 6 am) of each situation (arm) of the study for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Glucose concentration
Prevalence of hyperglycemia
Prevalence of hypoglycemia
+1 more
Secondary outcome measures
Feeling scale
Physical Activity Enjoyment Scale
Rating of Discomfort scale
+3 more

Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: low-effort sessionExperimental Treatment1 Intervention
Participants will perform sets with half of the anticipated number of repetitions of the high-effort session.
Group II: high-effort sessionExperimental Treatment1 Intervention
Participants will perform sets with as many repetitions they can each set.
Group III: Control sessionPlacebo Group1 Intervention
The control session all procedures will be identical to the high-effort session.

Find a Location

Who is running the clinical trial?

University of New MexicoLead Sponsor
372 Previous Clinical Trials
3,528,774 Total Patients Enrolled
Flavio De Castro Magalhaes, PhDPrincipal InvestigatorAssistant Professor

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment criteria for this medical study inclusive of individuals below the age of 45?

"To meet the eligibility criteria for this clinical trial, potential participants must be between 18 and 65 years old."

Answered by AI

Are there still available openings for new participants in this research study?

"As per the information available on clinicaltrials.gov, this specific trial is not currently actively seeking participants. The initial posting date was February 1st, 2024, and it was most recently updated on January 10th, 2024. However, there are currently a total of 1509 other ongoing clinical trials that are actively accepting candidates for participation."

Answered by AI
~10 spots leftby Jul 2024